I reported previously (10th Jun) results of trials of one pancreatic treatment at Israel’s Sheba hospital. Sheba are now starting Phase 3 trials of another, CPI-613 (devimistat) from Israeli biotech Rafael, which can also treat Acute Myeloid Leukemia and other cancers.
https://rafaelpharma.com/research-and-development/cpi-613-drug/